All terms in DRUGBANK

Label Id Description
D-Lysine DB03252 [An essential amino acid. It is often added to animal feed. [PubChem]]
(2s)-Pyrrolidin-2-Ylmethylamine DB03253
Phenyldehydroalanine DB04584
1-benzylimidazole DB04581 [1-benzylimidazole, an N-imidazole derivative, has been shown to have strong cardiotonic activity.]
2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole DB03250
RWJ-51084 DB03251
IMAZAQUIN DB04582
1-Methyl-2-quinolone DB04580
Olinciguat DB15238 [Olinciguat is under investigation in clinical trial NCT03892499 (A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers).]
Fluciclovine DB15237 [Fluciclovine is under investigation in clinical trial NCT03036943 (Fluciclovine (18F) Imaging of Breast Cancer).]
PTI-428 DB15239 [PTI-428 is under investigation in clinical trial NCT03258424 (Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background Therapy).]
Semorinemab DB15234 [Semorinemab is under investigation in clinical trial NCT03289143 (A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal to Mild Alzheimer's Disease).]
Avapritinib DB15233 [Avapritinib is under investigation in clinical trial NCT03862885 (Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GIST).]
Fucose DB15236 [Fucose is under investigation in clinical trial NCT03354533 (Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II).]
Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone DB15235 [Di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone is under investigation in clinical trial NCT02688101 (Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors).]
Dithiopyr DB15230 [Dithiopyr is under investigation in clinical trial NCT01236781 (Comparison of Full-Field Digital Mammography With Digital Breast Tomography for Screening Call-Back Rates).]
Telaglenastat DB15232 [Telaglenastat is under investigation in clinical trial NCT02071862 (Study of the Glutaminase Inhibitor CB-839 in Solid Tumors).]
Brimapitide DB15231 [Brimapitide is under investigation in clinical trial NCT01570205 (Safety, Tolerability and PK of a Single iv Infusion of 10, 40, and 80 µg/kg XG-102 Administered to Healthy Volunteers).]
2'-Deoxycytidine 5'-triphosphate DB03258
2',6'-Dichloro-Biphenyl-2,6-Diol DB03259